Berkshire Hathaway Sells $69M of DaVita Stock Amid HHS Kidney Reforms, Securities Fraud Probe
Berkshire Hathaway sold $69 million in DaVita shares as HHS unveils a kidney-care plan and Pomerantz investigates potential securities fraud.
International Business Times UK ·